HAINAN HULUWA PHARMACEUTICAL GROUP CO., LTD.

Highlights Hainan Huluwa Pharmaceutical Group Co., Ltd.

Equities

605199

CNE100004223

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 03/06/2024 BST			5-day change	1st Jan Change
10.85 ^CNY	+0.09%		-3.81%	-28.43%

05-01	Huluwa Pharmaceutical Gets Nod to Register Two Drugs	MT
04-26	Hainan Huluwa Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Huluwa Pharmaceutical Gets Nod to Register Two Drugs	05-01	MT
Hainan Huluwa Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-26	CI
Huluwa Pharma Gets Nod to Market Terbutaline Sulfate Inhaler	04-24	MT
Huluwa Pharma Gets Nod to Register Cefdinir Granules	02-20	MT
Hainan Huluwa Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	30/10/23	CI
Huluwa Pharmaceutical Gets Nod to Trial Epilepsy Drug	22/09/23	MT
Hainan Huluwa Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	28/08/23	CI
Hainan Huluwa Pharmaceutical Unit Gets Registration Certificate for Allergy Drug in China	04/08/23	MT
Huluwa Pharma's Supplementary Drug Application for Infection Treatment Wins Approval in China	06/06/23	MT
Hainan Huluwa Pharmaceutical Group Co., Ltd. completed the acquisition of 51% stake in Jiangxi Rongxing Pharmaceutical Co., Ltd. from Chen Xuerong.	19/04/23	CI
Hainan Huluwa Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	17/04/23	CI
Hainan Huluwa Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	17/04/23	CI
Hainan Huluwa Pharmaceutical Group Co., Ltd. entered into an agreement to acquire 51% stake in Jiangxi Rongxing Pharmaceutical Co., Ltd. from Chen Xuerong for CNY 44.88 million	16/03/23	CI
Hainan Huluwa Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	27/10/22	CI
Hainan Huluwa Pharma Cleared to Launch Clinical Trial of New Cough Treatment in China	08/09/22	MT
Hainan Huluwa Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	26/08/22	CI
Hainan Huluwa Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	28/04/22	CI
Hainan Huluwa Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	28/04/22	CI
Hainan Huluwa Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	28/10/21	CI
Hainan Huluwa Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	26/08/21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Hainan Huluwa Pharmaceutical Group Co., Ltd.

Equities

605199

CNE100004223

Highlights

Filters